Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)
Clinical trial NCT03780361 · COMPLETED
Trial details
- NCT number
- NCT03780361
- Sponsor
- Hyewon Chung
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-17
- Primary completion
- 2023-01-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.